IMBiotechnologies Ltd. are in the process of  obtaining regulatory approval to use our product (Occlusin® 500) to treat BPH.

View the video link:  https://vimeo.com/266405255

Please note that Occlusin® 500 Embolization Microspheres has been cleared by the US FDA for the treatment of unresectable/inoperable hypervascularized tumors.  Occlusin® 500 is not yet approved for use in the treatment of BPH.  IMBiotechnologies is collecting clinical data in support of obtaining regulatory approval for the treatment of BPH in various jurisdictions including the USA, Canada, and Europe.